医薬品リファレンス
Liposomal doxorubicin
Liposomal doxorubicin is a medicine in the class oncology. It is used for kaposi's sarcoma.
- 薬効分類: Oncology
- 効能・効果: kaposi's sarcoma
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
要点
- 薬効分類
- Oncology
- ATCコード
- L01DB01
- 既知の相互作用
- 146 (併用禁忌: 1 · 重大: 17 · 中等度: 70 · 軽度: 58)
- 商品名
- 1
- 国・市場
- 1
何に使われるか
作用のしくみ
Anthracycline; intercalates between DNA base pairs, impairs topoisomerase II function and subsequently inhibits DNA and RNA replication. Doxorubicin is a strong chelator; doxorubicin-iron complex binds to cell membranes and DNA and produces free hydroxyl radicals that cleaves them.
成人の通常用量（添付文書の要約）
Kaposi Sarcoma: 20 mg/m² IV q3Weeks
妊娠と授乳
- 妊娠
- Unsafe Can cause fetal harm: embryotoxic in rats and abortifacient in rabbits at low doses. Avoid in the 1st trimester; human data for doxorubicin later in pregnancy do not establish the risk, and any use needs specialist care. Use effective contraception during and for 6 months after treatment.
- 授乳
- Unsafe Not known if the liposomal form passes into milk; conventional doxorubicin and its active metabolite reach high, persistent levels. Because of possible serious infant reactions, do not breastfeed during treatment. LactMed: breastfeeding is generally contraindicated with anthracyclines.
報告されている副作用
- Nausea
- Asthenia
- Anemia
- Neutropenia
- Thrombocytopenia
- Stomatitis
注意が必要な方
- Based on animal data, can cause fetal harm when administered to pregnant women
- May include flushing, shortness of breath, facial swelling, headache, chills, back pain, tightness in the chest or throat
- Hypotension occurred in 11% of patients with solid tumors treated with liposomal doxorubicin
妊娠中または授乳中であること、腎臓や肝臓の病気、アレルギー、ほかに使用しているすべての薬やサプリメントについて、薬剤師または医師にお伝えください。
主な相互作用 (146)
- Dengue vaccine + Liposomal doxorubicin Contraindicated
- Belatacept + Liposomal doxorubicin Major
- Cyclosporine + Liposomal doxorubicin Major
- Dronedarone + Liposomal doxorubicin Major
- Elvitegravir / cobicistat / emtricitabine / tenofovir df + Liposomal doxorubicin Major
- Fingolimod + Liposomal doxorubicin Major
- Ganciclovir + Liposomal doxorubicin Major
- Itraconazole + Liposomal doxorubicin Major
- Ketoconazole + Liposomal doxorubicin Major
- Levoketoconazole + Liposomal doxorubicin Major
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、Liposomal doxorubicinの完全なモノグラフ（用量、妊娠・授乳、副作用、警告、すべての相互作用）を表示できます。
- Dosing by age, kidney and liver function, and further dose lines
- Paediatric dosing
- Patient counselling points
- Food interactions
WebでPro+を14日間無料でお試し。カード登録不要。
同じ分類のほかの薬剤
よくある質問
What is Liposomal doxorubicin used for?
Liposomal doxorubicin is a medicine in the class oncology. It is used for Kaposi's sarcoma, Multiple myeloma, Ovarian cancer.
What side effects have been reported with Liposomal doxorubicin?
Nausea, Asthenia, Anemia, Neutropenia, Thrombocytopenia, Stomatitis.
Can Liposomal doxorubicin be taken in pregnancy or while breastfeeding?
Pregnancy: Unsafe. Can cause fetal harm: embryotoxic in rats and abortifacient in rabbits at low doses. Avoid in the 1st trimester; human data for doxorubicin later in pregnancy do not establish the risk, and any use needs specialist care. Use effective contraception during and for 6 months after treatment. Breastfeeding: Unsafe. Not known if the liposomal form passes into milk; conventional doxorubicin and its active metabolite reach high, persistent levels. Because of possible serious infant reactions, do not breastfeed during treatment. LactMed: breastfeeding is generally contraindicated with anthracyclines.
What does Liposomal doxorubicin interact with?
MediHelp lists 146 known interactions for Liposomal doxorubicin. Contraindicated: 1 · Major: 17 · Moderate: 70 · Minor: 58. The most serious include Dengue vaccine, Belatacept, Cyclosporine.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
